Cover Image

Use of gabapentin to reduce chronic neuropathic pain in Fabry disease

The effect of the anticonvulsant gabapentin on neuropathic pain was studied in six male patients with Fabry disease, aged 15-45 years. After 4 weeks of treatment, pain, as measured using the Brief Pain Inventory, was decreased compared with baseline. Treatment was generally well tolerated. This stud...

Full description

Saved in:
Bibliographic Details
Main Authors: Ries, Markus (Author) , Mengel, Eugen (Author) , Kutschke, G. (Author) , Kim, K. S. (Author) , Birklein, F. (Author) , Krummenauer, Frank (Author) , Beck, Michael (Author)
Format: Article (Journal)
Language:English
Published: 01 June 2003
In: Journal of inherited metabolic disease
Year: 2003, Volume: 26, Issue: 4, Pages: 413-414
ISSN:1573-2665
DOI:10.1023/A:1025127723729
Online Access:Verlag, Volltext: https://doi.org/10.1023/A:1025127723729
Verlag, Volltext: https://onlinelibrary.wiley.com/doi/abs/10.1023/A%3A1025127723729
Get full text
Author Notes:M. Ries, E. Mengel, G. Kutschke, K.S. Kim, F. Birklein, F. Krummenauer and M. Beck
Description
Summary:The effect of the anticonvulsant gabapentin on neuropathic pain was studied in six male patients with Fabry disease, aged 15-45 years. After 4 weeks of treatment, pain, as measured using the Brief Pain Inventory, was decreased compared with baseline. Treatment was generally well tolerated. This study indicates that gabapentin should be considered as a treatment option for the neuropathic pain of Fabry disease.
Item Description:Gesehen am 16.05.2019
Physical Description:Online Resource
ISSN:1573-2665
DOI:10.1023/A:1025127723729

Similar Items